New treatment to reduce asthma severity – Promising AirPROM study
The University of Leicester has led a ground-breaking study, funded by Novartis Pharmaceuticals, National Institute for Health Research (NIHR) and EU-funded project AirPROM, on a new drug that may in  ...

Read more

AirPROM legacy – Check out the booklet
The AirPROM project ended in May 2016, with a public event organised by EFA at the European Parliament, hosted by MEP David Borrelli. However the work does not finish when a project ends, especially w ...

Read more

Chronic diseases in Europe: the Commission is urged to act
EFA, the European Chronic Diseases Alliance (ECDA) and other public health organisations have sent an open letter to the European Commission urging them to act on chronic diseases. Chronic diseases  ...

Read more

European Medicines Agency celebrates 10 years of collaboration with patients
Our continuous input into the information, evaluation and safety and development policies of medicines in Europe is an achievement that we celebrate, especially after the renewal of EFA membership to  ...

Read more

EFA brings the patients’ perspective to the Medicines for Europe event
On the 9th of June, EFA Senior EU Policy Adviser and Deputy Director Roberta Savli took part in a panel discussion on so-called value-added medicines organised in the framework of the Joint 22nd Medic ...

Read more

European Patient Charter presented
In the framework of the Patient Empowerment campaign, the European Patients’ Forum (EPF) has launched the European Patient Charter and a Roadmap for patient empowerment. EFA, as full Member and Board  ...

Read more

EU conclusions to make more balanced pharmaceutical systems
On the 17th of June, the Council of the European Union issued conclusions on strengthening the balance in the pharmaceutical systems in the EU and its Member States. The Council recognises the importa ...

Read more

EFA statement on value and pricing of innovative medicines
EFA shares the European Patients’ Forum (EPF) view that health is a fundamental right for everyone and therefore medicines, which allow for this right to be fully enjoyed by all people, should not be  ...

Read more

Treat the person, not the disease – Outcomes of the Personalised Medicine Conference
Personalised medicine is seen as part of a wider shift from disease-centred to person-centred healthcare, from one-size-fits-all, to individualized treatment and prevention. “To realise this shift, pa ...

Read more

Take part in the Commission public consultations for patient-friendly clinical trials
In the month of June, the European Commission has launched four new public consultations on clinical trials. The consultations are on risk proportionate approaches, on the summary of the clinical tria ...

Read more

More investment for prevention – Conclusions of European Health Parliament
On the 29th June, we participated in the European Health Parliament (EHP) closing session to bring the perspective of allergy, asthma and COPD patients. The European Health Parliament is a platform, ...

Read more

How to use allergy medication
Material: This series of videos presents the different spacers and peak flow meters (PFM) and shows how to use them correctly. There are guidelines to help patients and healthcare professionals.& ...

Read more

AirPROM brings a promising scanning tool for respiratory patients
EFA organised the final event of AirPROM, an EU funded project that during five years has pulled out the best knowledge of lung research in Europe to come up with a virtual model of the human lungs. E ...

Read more

EU adopts new rules for medical devices – Patients will have better information on devices
On the 25th of May 2016, the Netherlands Presidency of the Council of the European Union and representatives of the European Parliament agreed new rules for evaluation and market access of medical dev ...

Read more

EFA delivered the patient perspective at the Medicines for Europe launch
For patients the value of medicines is all about how it works for their particular condition and that their benefit and safety balance fits with the individual goals for treatment, ideally discussed a ...

Read more

EFA asthma patient leaders launch the Málaga-London Declaration (EARIP)
EFA together with our membership, and under the leadership of Asthma UK, have launched the Malaga-London declaration, a document drafted within the European Asthma Research and Innovation Partnership  ...

Read more

Guide for parents of children and young people with asthma, with self-management advice
Material: A guide for parents of children and young people with asthma, with self-management advice Original name: Lasten ja nuorten astma and Astma hos barn och unga Author: The Organis ...

Read more

World Asthma Day - Young patients have something to say about asthma
Adolescent patients with asthma encounter difficulties in following their medication but the reasons are unclear; HEY YA! HEalth Literacy, Young Patients with Asthma and Adherence to treatment: EFA Re ...

Read more

PRESS RELEASE: Young patients with asthma need more investment in technology and health literacy
Young patients with asthma need more investment in technology and health literacy Brussels, 28 April, 2016 – BEFORE WORLD ASTHMA DAY. Asthma is the most common chronic disease in childhood. Today, 3 ...

Read more

Patients’ views on the Medical Devices Regulation
On the 22nd of February, Senior EU Policy Advisor Roberta Savli met with the assistant of Mrs Wilmot MEP (rapporteur of the medical devices regulation in the European Parliament) together with the Eur ...

Read more

Dear Visitor,

for regularly updated information on Covid-19 for allergy and respiratory patients, please consult our Covid-19 resource and information hub.
Stay safe!
The EFA Team